Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials

Authors:

Published: 2022-01-18

DOI: 10.1136/bmj.o109

Source: Full article


Abstract

No abstract found.